A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis.
作者信息
Deng Guofang, Fu Liang
机构信息
Pulmonary Diseases Department, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China; National Clinical Research Center for Infectious Disease (Shenzhen), Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis), Shenzhen Clinical Research Center for Tuberculosis, Shenzhen, China.
Pulmonary Diseases Department, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China; National Clinical Research Center for Infectious Disease (Shenzhen), Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis), Shenzhen Clinical Research Center for Tuberculosis, Shenzhen, China.
出版信息
Lancet Infect Dis. 2024 Sep;24(9):940-941. doi: 10.1016/S1473-3099(24)00257-3. Epub 2024 May 17.
Zotero 插件